These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 8517172)
1. Mortality in major affective disorder: relationship to subtype of depression. The Danish University Antidepressant Group. Buchholtz-Hansen PE; Wang AG; Kragh-Sørensen P Acta Psychiatr Scand; 1993 May; 87(5):329-35. PubMed ID: 8517172 [TBL] [Abstract][Full Text] [Related]
2. [Mortality--suicide and natural death--among depressed patients. Relation to type of depression]. Hansen PE; Wang AG; Kragh-Sørensen P Ugeskr Laeger; 1994 Nov; 156(48):7224-8. PubMed ID: 7817434 [TBL] [Abstract][Full Text] [Related]
3. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group. Psychopharmacology (Berl); 1986; 90(1):131-8. PubMed ID: 2876451 [TBL] [Abstract][Full Text] [Related]
4. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382 [TBL] [Abstract][Full Text] [Related]
5. Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs. patients treated by their family doctors. Danish University Antidepressant Group. Fuglum E; Rosenberg C; Damsbo N; Stage K; Lauritzen L; Bech P Acta Psychiatr Scand; 1996 Jul; 94(1):18-25. PubMed ID: 8841672 [TBL] [Abstract][Full Text] [Related]
6. Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5). Licht RW; J Affect Disord; 2013 Jun; 148(2-3):286-90. PubMed ID: 23399479 [TBL] [Abstract][Full Text] [Related]
8. [Antidepressants consumption in the global population in France]. Olié JP; Elomari F; Spadone C; Lépine JP Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542 [TBL] [Abstract][Full Text] [Related]
9. Paroxetine versus placebo: a double-blind comparison in depressed patients. Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression. Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348 [TBL] [Abstract][Full Text] [Related]
11. The WHO Depression Scale. Relationship to the Newcastle Scales. Bech P; Gram LF; Reisby N; Rafaelsen OJ Acta Psychiatr Scand; 1980 Aug; 62(2):140-53. PubMed ID: 7468286 [TBL] [Abstract][Full Text] [Related]
12. Citalopram--a specific 5-HT-reuptake inhibitor--as an antidepressant drug: a phase II multicentre trail. Ofsti E Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):327-35. PubMed ID: 6959197 [TBL] [Abstract][Full Text] [Related]
13. Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Oquendo MA; Malone KM; Ellis SP; Sackeim HA; Mann JJ Am J Psychiatry; 1999 Feb; 156(2):190-4. PubMed ID: 9989553 [TBL] [Abstract][Full Text] [Related]
14. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients. Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467 [TBL] [Abstract][Full Text] [Related]
15. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials. Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354 [TBL] [Abstract][Full Text] [Related]
17. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Tondo L; Lepri B; Baldessarini RJ Acta Psychiatr Scand; 2008 Aug; 118(2):106-15. PubMed ID: 18397362 [TBL] [Abstract][Full Text] [Related]
18. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. Mavissakalian M; Turner SM; Michelson L; Jacob R Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761 [TBL] [Abstract][Full Text] [Related]
19. Long term follow up of suicide in a clinically depressed community sample. Thomson W J Affect Disord; 2012 Jun; 139(1):52-5. PubMed ID: 22425433 [TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]